Inflammation, oxidative stress and wound healing after ablation of atrial fibrillatio

Not Applicable

Completed

• Conditions: Atrial fibrillation; Circulatory System

• Registration Number: ISRCTN89619994
• Lead Sponsor: Medical University of Vienna (Austria)

Brief Summary

1. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/20692054 (added 31/05/2019) 2. 2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/22102100 (added 31/05/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-12-11
• Study Completion: 2008-08-01
• Last Update Posted: 26 June 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Genders eligible for study: both
2. Age older than 18 years
3. Symptomatic, drug-resistant paroxysmal atrial fibrillation (self-terminating episodes lasting less than 7 days)
4. Patients referred to our department for catheter ablation of atrial fibrillation
5. Adequate anticoagulation for at least 1 month prior to admission (oral anticoagulation (target International Normalised Ratio [INR] 2 to 3) or treatment with weight-adjusted low-molecular-weight heparin

Exclusion Criteria

1. Pregnancy
2. Ongoing infections
3. Intracardiac thrombosis detected by trans-oesophageal echocardiography
4. Contraindications to anticoagulation
5. History of myocardial infarction or cardiac surgery within the last 3 months prior to admission
6. Pacemaker or other contraindications to Magnetic Resonance Imaging (MRI)
7. Denial or withdrawal of informed consent
8. Life expectancy less than 1 year

Study & Design

• Study Type: Observational
• Study Design: Not specified